End-to-End 10x Visium V1 Spatial Transcriptomics Services
We offer an end-to-end 10x Visium V1 spatial transcriptomics service that maps whole transcriptomes directly to histological structures. By preserving native spatial architecture lost in bulk sequencing and avoiding cell-state alterations from tissue dissociation, this service resolves tissue heterogeneity, helping you confidently identify localized biomarkers and target mechanisms.
- Optimized preparation for Fresh Frozen and OCT-embedded samples.
- Strict QC checkpoints to secure your precious tissue assets.
- Advanced spot deconvolution using MIA and RCTD algorithms.
Resolving Spatial Heterogeneity with 10x Visium V1
Traditional bulk RNA sequencing loses the physical architecture of tissues, yielding only an averaged expression profile. Conversely, standard single-cell RNA sequencing (scRNA-seq) requires enzymatic or mechanical tissue dissociation, stripping away critical spatial context and potentially inducing stress-response transcriptional artifacts. The 10x Genomics Visium V1 platform addresses this gap by capturing transcriptomic data directly from intact tissue sections, marrying histological morphology with high-plex molecular profiling.
Each standard Visium V1 slide features four distinct capture areas, each measuring exactly 6.5mm × 6.5mm. Within each of these capture areas, a printed array contains 5,000 uniquely barcoded spots.
- Spot Dimensions: Each individual spot has a diameter of 55µm and is spaced 100µm apart from center to center.
- Cellular Capture Coverage: Depending on the specific tissue type, cell morphology, and local cell density, a single 55µm spot typically captures transcripts from an aggregate of 1 to 10 cells.
- Barcoding Mechanism: Millions of capture probes bind to poly-A mRNA directly on the slide surface immediately following tissue permeabilization. Each probe contains a spatial barcode to securely record physical (x,y) coordinates and a distinct molecular sequence tag to achieve absolute transcript quantification, enabling the computational removal of library amplification duplicates.
While the 55µm physical resolution of the V1 platform provides a highly accurate broad anatomical map, characterizing individual cell types within a single spot requires specialized computational approaches. Our service focuses on pairing the established Visium V1 hardware with advanced data unmixing techniques to mathematically estimate specific cell-type proportions within each spot, effectively bridging the gap between multi-cellular spots and single-cell resolution.
Diverse Applications in Translational Research
Maintaining the morphological context of gene expression opens new analytical dimensions for translational research. We support researchers across multiple therapeutic areas by providing data that links molecular profiles to physical structures using the Visium V1 system. Understanding where a gene is expressed is often as critical as understanding how much it is expressed.
Oncology & the Tumor Microenvironment (TME)
Solid tumors are complex ecosystems where malignant cells interact constantly with stroma, vasculature, and immune infiltrates. Visium V1 allows us to map the spatial distribution of immune cells relative to tumor boundaries. Researchers can identify specific regions of immune exclusion, mapping where cytotoxic T cells are halted by fibrotic stroma. Furthermore, plotting gene co-expression over tissue histology can reveal localized pockets of immune exhaustion, tertiary lymphoid structures (TLS), or spatial variations in therapeutic target expression (such as PD-L1 gradients).
Developmental Biology and Organogenesis
Tracking gene expression changes across developing organ structures requires precise spatial temporal mapping. Visium V1 enables the assignment of specific transcriptomic profiles to distinct anatomical layers without the need for error-prone physical microdissection. This is critical for mapping morphogen gradients, lineage tracing in native tissues, and understanding how cellular neighborhoods dictate differentiation pathways during embryonic development.
Neuroscience and Neurodegeneration
The mammalian brain possesses highly ordered, layered architectures that govern function. We utilize Visium V1 to characterize the spatial organization of cortical layers and discrete nucleated regions. In neurodegenerative disease models, such as Alzheimer's or Parkinson's, spatial transcriptomics can identify localized pathological markers—mapping activated microglial or astrocytic signatures directly adjacent to amyloid-beta plaques or tau tangles, isolating the transcriptomic response of the immediate microenvironment.
Infectious Disease and Localized Inflammation
Systemic readouts often fail to capture the localized nature of host-pathogen interactions. By employing spatial transcriptomics on infected tissue sections, researchers can map the exact architecture of granulomas, viral entry sites, or localized inflammatory cascades. This allows for the correlation of specific cytokine or chemokine expression gradients with the physical proximity of the infectious agent or the resulting tissue damage.
Streamlined Workflow & Stringent QC Checkpoints
Processing fragile tissue sections requires strict adherence to standardized operating procedures. Our laboratory workflow is designed to maximize data recovery while implementing multiple Quality Control (QC) checkpoints. If a sample fails to meet baseline criteria at any QC step, we pause the project and consult with you, preventing the unnecessary consumption of high-value clinical or research samples.
End-to-end workflow for 10x Visium V1 spatial transcriptomics, integrating histological imaging with molecular barcoding.
- Sample Preparation and Initial QC
Projects begin with the reception of Fresh Frozen, OCT-embedded tissue blocks. We perform initial sectioning and assess tissue integrity. A critical QC checkpoint is evaluating the RNA Integrity Number (RIN). For optimal Visium V1 performance, a RIN of ≥ 7 is highly recommended, as highly degraded RNA will diffuse laterally or fail to bind the surface probes, resulting in poor spatial mapping and low transcript counts.
- Tissue Optimization and Imaging
Before processing the actual experimental sections, we conduct a dedicated Tissue Optimization assay. This step determines the precise permeabilization time required for your specific tissue type to release mRNA efficiently without causing lateral diffusion that blurs the spatial signal. Once optimized, experimental sections are placed on the Visium V1 slide, fixed, and stained (typically with H&E for morphological context or Immunofluorescence for protein co-detection). High-resolution brightfield or fluorescent imaging captures the tissue architecture for downstream alignment.
- Permeabilization and cDNA Synthesis
The tissue is permeabilized under precisely timed conditions, allowing cellular mRNA to migrate directly downward and bind to the spatially barcoded oligo-dT probes on the slide. Reverse transcription is performed directly on the slide surface to synthesize stable cDNA. Each transcript is labeled with a unique molecular sequence tag to ensure precise quantification during the subsequent analysis phase.
- Library Construction and Sequencing
The synthesized cDNA is chemically cleaved from the slide, amplified, and processed into Illumina-compatible sequencing libraries. A final library QC assesses fragment size distribution and molar concentration to ensure optimal clustering before loading onto a high-throughput sequencing platform.
Sample Submission Requirements
Proper sample preservation is the most critical factor in a spatial transcriptomics project. We have established clear guidelines to ensure your tissues remain viable for downstream capture on the V1 slides.
| Sample Type | Preservation Method | Max Dimensions | Recommended Thickness | Shipping Notes |
|---|---|---|---|---|
| Tissue Block | OCT Embedded (Fresh Frozen) | 8mm × 6mm | 10µm | Ship via priority courier on sufficient dry ice. |
| Pre-mounted Slides | Placed on Visium V1 slides | 6.5mm × 6.5mm | 10µm | Contact our team for pre-mounting protocols and slide transport boxes. |
Note: The 8mm × 6mm maximum block size ensures the section fits comfortably within the 6.5mm × 6.5mm capture area without overlapping the slide boundaries, which can cause coverslip sealing failures.
Comprehensive Bioinformatics: From Standard to Advanced Analysis
Generating sequencing reads is only the first phase. Translating Visium V1 data into actionable biological insights requires a structured, rigorous computational pipeline. We offer a tiered bioinformatics approach, moving from fundamental Space Ranger outputs to deep algorithmic exploration.
For projects aiming to integrate spatial data with existing single-cell datasets, explore our single-cell RNA sequencing services to generate the highly specific reference maps needed for optimal spatial deconvolution.
Comprehensive bioinformatics pipeline, expanding from standard processing defaults to advanced spatial deconvolution and cell-cell communication.
Standard Data Deliverables
Our standard bioinformatics package provides the necessary foundation for all downstream spatial analysis, ensuring data fidelity and accurate histological mapping:
- Raw Data QC: Comprehensive FastQC assessment of sequencing read quality, duplication rates, and GC content.
- Sequence Alignment: Mapping reads to the reference genome and accurately assigning them to spatial barcodes based on the V1 slide architecture.
- Gene Quantification: Generating transcript count matrices linked mathematically to physical spot coordinates.
- Basic Clustering: Unsupervised clustering of spots based on whole-transcriptome gene expression profiles, overlaid directly onto the corresponding H&E image to define broad tissue domains.
Advanced Spatial Data Mining
To overcome the inherent limitations of the 55µm spot size (which invariably contains mixtures of multiple cell types in dense tissues), we deploy specialized algorithms designed to deconvolve spot mixtures, trace lineages, and map cellular interactions:
- Spatial Cell Type Identification (Deconvolution): We utilize sophisticated algorithms such as MIA (Multimodal Intersection Analysis) and RCTD (Robust Cell Type Decomposition). RCTD, for instance, uses a maximum likelihood estimation framework to estimate the exact proportions of different cell types within a single spot. This requires using your own or public high-quality scRNA-seq data as an annotated reference.
- Spatial Communication Analysis: Employing spatial tools like CellphoneDB, we infer potential ligand-receptor interactions between neighboring spatial spots. By identifying where a ligand is expressed in one spot and its corresponding receptor in an adjacent spot, we can map localized signaling networks.
- Spatial Trajectory Inference: Using algorithms such as monocle2 adapted for spatial data or STlearn, we reconstruct pseudotime trajectories to trace cellular development or functional state transitions (e.g., T cell exhaustion gradients) across the physical tissue space.
- Tumor Boundary Mapping: Implementing specialized models like Cottrazm to precisely mathematically define tumor margins, allowing for the targeted analysis of the localized immune microenvironment residing explicitly at the invasive front.
Demo Results: Visualizing the Tumor Microenvironment
Our analysis reports include high-fidelity, publication-ready figures that clearly communicate complex spatial data. Below are typical visual outputs generated from our advanced computational pipeline.
Visualizing spatial heterogeneity, localized cell abundance, and cellular trajectories across physical tissue sections.
- Spatial Clustering Maps: Visualization of transcriptomic clusters projected directly onto the histological image. These maps demonstrate how molecular signatures perfectly align with anatomical features, such as cleanly separating reactive stroma from necrotic tumor nests.
- Spatial Trajectory (Pseudotime) Projections: Directional trees and spatial projections showing the spatial progression of cell states. This is particularly useful for visualizing the gradual functional exhaustion of infiltrating T cells as they migrate closer to the hypoxic tumor core.
- Cell Type Abundance Heatmaps: Color-scaled intensity maps indicating the estimated density and physical localization of specific cell populations (e.g., immunosuppressive macrophages or cancer-associated fibroblasts) within individual 55µm spots, derived directly from RCTD deconvolution results.
Case Study: High-Resolution Mapping of the TME
Source: High resolution mapping of the tumor microenvironment using integrated single-cell, spatial and in situ analysis (Nature Communications, 2023)
Background
Resolving the precise physical boundaries between malignant cells and the surrounding tumor-associated stroma is critical for understanding tumor progression and immune exclusion. Researchers needed to identify specific, localized cellular niches that actively drive immune evasion in breast cancer, a task impossible with bulk sequencing.
Methods
The study utilized the 10x Visium platform combined with matched single-cell RNA sequencing reference data. By employing rigorous integration and deconvolution algorithms similar to our advanced pipeline, the team mathematically mapped distinct cell states onto intact tissue sections, specifically focusing their analysis on the immediate interface between the tumor border and the surrounding microenvironment.
Results
The spatial analysis successfully identified highly specialized cellular neighborhoods that standard bulk sequencing entirely missed. The resulting spatial maps detailed the exact locations of varied immune cell infiltrations relative to the tumor margins. Crucially, the data revealed spatially restricted populations of exhausted CD8+ T cells and immunosuppressive macrophages colocalized at the invasive front, supported by integrated transcriptomic atlases.
Conclusion
The application of Visium V1 spatial transcriptomics, paired with rigorous computational deconvolution, provided a high-resolution view of the TME. This validated the platform's utility in identifying spatially restricted therapeutic targets and mapping the physical barriers to immune infiltration.
Solution Selection: Maximizing Your Spatial Data
Selecting the right transcriptomic approach depends entirely on your specific research question, required resolution, and the availability of tissue samples. Use the framework below to guide your project design and ensure you select the assay that yields the most actionable data.
| Parameter | Standard Bulk RNA-seq | Standard scRNA-seq | 10x Visium V1 (with Deconvolution) |
|---|---|---|---|
| Spatial Context | None (Homogenized) | None (Dissociated) | Retained (Mapped to Histology) |
| Physical Resolution | Entire Tissue Section | Single Cell | 55µm spots (1-10 cells per spot) |
| Tissue State | Lysed | Dissociated Suspension | Intact Section |
| Primary Challenge Solved | Average gene expression profiling across cohorts | Identifying rare cell types and deep cellular states | Mapping anatomical gene expression to structures |
When to Choose Visium V1:
- Select Visium V1 as your baseline assay when you need to map broad anatomical domains, trace structural biomarkers, and identify gene expression variations across distinct tissue architectures.
- Add our Advanced Deconvolution Module if you are investigating complex, highly infiltrated tissues where multiple cell types co-exist within a 55µm radius, allowing you to mathematically infer single-cell spatial arrangements.
- Consider conducting a parallel standard scRNA-seq project alongside your spatial run if you lack a robust, highly specific single-cell reference dataset for your exact tissue model. This matched reference is required to achieve the highest possible accuracy and statistical confidence during Visium V1 spot deconvolution.
Frequently Asked Questions (FAQs)
References
- Visium Spatial Gene Expression | 10x Genomics
- High resolution mapping of the tumor microenvironment using integrated single-cell, spatial and in situ analysis (Nature Communications, 2023)
